Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: China Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20154
20161
20173
20181
20194
20209
202110
202210
202310
202411
202511
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status32
Recruiting25
Completed11
Not yet recruiting10
Active, not recruiting5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University5
Sun Yat-sen University5
Bai-Rong Xia3
Peking Union Medical College Hospital3
Shanghai Gynecologic Oncology Group3
Akeso2
Anhui Provincial Cancer Hospital2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Chinese PLA General Hospital2
Fujian Cancer Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms84
Fallopian Tube Neoplasms15
Uterine Cervical Neoplasms9
Endometrial Neoplasms8
Carcinoma, Ovarian Epithelial7
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Genital Neoplasms, Female4
Ovarian Diseases4
Recurrence4

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.